Stifel Financial’s LianBio American Depositary Shares LIAN Stock Holding History

Stifel Financial’s Portfolio LIAN Stock Details LIAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-18,500	Closed	-$82.7K	–	3453
2023 Q4	$82.7K	Buy	18,500 +466	+3%	+$1.6K	﹤0.01%	3183
2023 Q3	$26.9K	Hold	18,034	–	–	﹤0.01%	3233
2023 Q2	$41.1K	Sell	18,034 -5,500	-23%	-$12.6K	﹤0.01%	3250
2023 Q1	$46.1K	Buy	23,534 +2,284	+11%	+$4.73K	﹤0.01%	3237
2022 Q4	$34.9K	Buy	+21,250	New	+$33.1K	﹤0.01%	3213

Other funds holding LIAN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Stifel Financial's LIAN Position: Q1 2024 in Review

Stifel Financial sold out of LianBio American Depositary Shares (LIAN) in Q1 2024, closing a stake of 18,500 shares — an estimated $82.7K sold.

Stifel Financial first reported a position in LIAN in Q4 2022 and held it in 5 quarters. The position peaked at $82.7K in Q4 2023. 3 funds tracked by Wall St. Rank hold LIAN as of Q1 2024.

Stifel Financial reported no remaining LianBio American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Stifel Financial sold 18,500 LianBio American Depositary Shares shares in Q1 2024, an estimated $82.7K.
Stifel Financial first reported a position in LianBio American Depositary Shares in Q4 2022 and held it in 5 quarters.
Stifel Financial's LianBio American Depositary Shares position peaked at $82.7K in Q4 2023.
3 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q1 2024.

Based on Stifel Financial's 13F filing for Q1 2024, filed 14 May 2024.